Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing beta-lactamases.

Literature DB >> 17005839

SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing beta-lactamases.

Anne Marie Queenan¹, Wenchi Shang, Paul Schreckenberger, Karen Lolans, Karen Bush, John Quinn.

Abstract

Imipenem-resistant Serratia marcescens isolates were cultured from a lung transplant patient given multiple antibiotics over several months. The strains expressed SME-3, a beta-lactamase of the rare SME carbapenem-hydrolyzing family. SME-3 differed from SME-1 by a single amino acid substitution of tyrosine for histidine at position 105, but the two beta-lactamases displayed similar hydrolytic profiles.

Entities: Chemical Mutation Species

Mesh：

Substances：

Year: 2006 PMID： 17005839 PMCID： PMC1610102 DOI： 10.1128/AAC.00363-06

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

15 in total

1. Achieving 100% typeability of Pseudomonas aeruginosa by pulsed-field gel electrophoresis.

Authors: U Römling; B Tümmler
Journal: J Clin Microbiol Date: 2000-01 Impact factor: 5.948

2. A standard numbering scheme for the class A beta-lactamases.

Authors: R P Ambler; A F Coulson; J M Frère; J M Ghuysen; B Joris; M Forsman; R C Levesque; G Tiraby; S G Waley
Journal: Biochem J Date: 1991-05-15 Impact factor: 3.857

3. Effective cooling allows sonication to be used for liberation of beta-lactamases from gram negative bacteria.

Authors: K Bush; S B Singer
Journal: J Antimicrob Chemother Date: 1989-07 Impact factor: 5.790

4. Biochemical characterization of a beta-lactamase that hydrolyzes penems and carbapenems from two Serratia marcescens isolates.

Authors: Y J Yang; P J Wu; D M Livermore
Journal: Antimicrob Agents Chemother Date: 1990-05 Impact factor: 5.191

5. Carbapenem-resistant Serratia marcescens isolates producing Bush group 2f beta-lactamase (SME-1) in the United States: results from the MYSTIC Programme.

Authors: A C Gales; D J Biedenbach; P Winokur; D M Hacek; M A Pfaller; R N Jones
Journal: Diagn Microbiol Infect Dis Date: 2001-02 Impact factor: 2.803

Review 6. A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors: K Bush; G A Jacoby; A A Medeiros
Journal: Antimicrob Agents Chemother Date: 1995-06 Impact factor: 5.191

Review 7. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors: F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal: J Clin Microbiol Date: 1995-09 Impact factor: 5.948

8. Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria.

Authors: R B Sykes; D P Bonner; K Bush; N H Georgopapadakou
Journal: Antimicrob Agents Chemother Date: 1982-01 Impact factor: 5.191

9. Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A beta-lactamase, Sme-1, from Serratia marcescens S6.

Authors: T Naas; L Vandel; W Sougakoff; D M Livermore; P Nordmann
Journal: Antimicrob Agents Chemother Date: 1994-06 Impact factor: 5.191

10. Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli.

Authors: P Nordmann; S Mariotte; T Naas; R Labia; M H Nicolas
Journal: Antimicrob Agents Chemother Date: 1993-05 Impact factor: 5.191

17 in total

Review 1. Carbapenemases: the versatile beta-lactamases.

Authors: Anne Marie Queenan; Karen Bush
Journal: Clin Microbiol Rev Date: 2007-07 Impact factor: 26.132

2. SME-2-producing Serratia marcescens isolate from Switzerland.

Authors: Laurent Poirel; Aline Wenger; Jacques Bille; Sandrine Bernabeu; Thierry Naas; Patrice Nordmann
Journal: Antimicrob Agents Chemother Date: 2007-04-09 Impact factor: 5.191

3. In vitro susceptibility of β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE) to eravacycline.

Authors: Yunliang Zhang; Xiaoyan Lin; Karen Bush
Journal: J Antibiot (Tokyo) Date: 2016-06-29 Impact factor: 2.649

4. Genetic and Biochemical Characterization of FRI-1, a Carbapenem-Hydrolyzing Class A β-Lactamase from Enterobacter cloacae.

Authors: Laurent Dortet; Laurent Poirel; Samia Abbas; Saoussen Oueslati; Patrice Nordmann
Journal: Antimicrob Agents Chemother Date: 2015-09-21 Impact factor: 5.191

Review 5. Epidemiology of β-Lactamase-Producing Pathogens.

Authors: Karen Bush; Patricia A Bradford
Journal: Clin Microbiol Rev Date: 2020-02-26 Impact factor: 26.132

6. Activity of Imipenem-Relebactam and Meropenem-Vaborbactam against Carbapenem-Resistant, SME-Producing Serratia marcescens.

Authors: M Biagi; A Shajee; A Vialichka; M Jurkovic; X Tan; E Wenzler
Journal: Antimicrob Agents Chemother Date: 2020-03-24 Impact factor: 5.191

7. Class A carbapenemase FPH-1 from Francisella philomiragia.

Authors: Marta Toth; Viktoria Vakulenko; Nuno T Antunes; Hilary Frase; Sergei B Vakulenko
Journal: Antimicrob Agents Chemother Date: 2012-03-26 Impact factor: 5.191

8. Novel ambler class A carbapenem-hydrolyzing beta-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France.

Authors: Delphine Girlich; Laurent Poirel; Patrice Nordmann
Journal: Antimicrob Agents Chemother Date: 2009-11-09 Impact factor: 5.191

9. Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.

Authors: Anne Marie Queenan; Wenchi Shang; Robert Flamm; Karen Bush
Journal: Antimicrob Agents Chemother Date: 2009-11-02 Impact factor: 5.191

10. Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.

Authors: Anne Marie Queenan; Wenchi Shang; Malgosia Kania; Malcolm G P Page; Karen Bush
Journal: Antimicrob Agents Chemother Date: 2007-06-25 Impact factor: 5.191